Lubombo Health Performance Report 2015
Total Page:16
File Type:pdf, Size:1020Kb
SI A Y I N Q A B KINGDOM OF SWAZILAND MINISTRY OF HEALTH REGIONAL HEALTH PERFORMANCE REPORT LUBOMBO REGION 2015 Strategic Information Department This publication was produced with the support of the United States Agency for International Development (USAID) under the terms of MEASURE Evaluation cooperative agreement AID-0AA-L-14-00004. Views expressed are not necessarily those of USAID or the United States government TABLE OF CONTENTS List of acronyms...........................................................................................................................................v Acknowledgements.....................................................................................................................................vi Executive summary....................................................................................................................................vii Annual Regional Objectives......................................................................................................................viii CHAPTER 1: Introduction...............................................................................................................1 1.1 Regional background.....................................................................................................2 1.1.1 Geographic Location......................................................................................................2 1.1.2 Population profile...........................................................................................................2 1.1.4 Determinants of Health.................................................................................................3 1.2 National Guidance..........................................................................................................4 1.2.1 Vision...............................................................................................................................4 1.2.2 Mission............................................................................................................................4 1.3 Leadership and Governance.......................................................................................4 1.3.1 Health system structure................................................................................................4 1.3.2 Regional Health Management Team............................................................................4 1.3.3 Report Overview.............................................................................................................6 1.3.4 Data sources...................................................................................................................6 1.3.5 Report writing process...................................................................................................6 CHAPTER 2: Management of In-Patients.....................................................................................7 2.1 In-patient mortality........................................................................................................8 2.2 Disease-burden..............................................................................................................9 2.3 Length of stay...............................................................................................................12 CHAPTER 3: Management of Out-Patients................................................................................13 3.1 Disease Burden............................................................................................................14 3.2 Notifiable conditions...................................................................................................17 3.3 Sexually Transmitted Illnesses (STIs).........................................................................18 CHAPTER 4: Health Services Outcomes.....................................................................................19 4.1 Promoting Health through the life course.................................................................20 4.1.1. ANTENATAL CARE (ANC)..............................................................................................20 4.1.2. Deliveries......................................................................................................................21 4.1.3 PREGNANCIES PROTECTED AGAINST TETANUS TOXOID (TT)..................................22 4.1.4 SYPHILIS AMONG PREGNANT WOMEN.....................................................................23 4.1.5 POST NATAL CARE (PNC).............................................................................................23 4.2 CHILD HEALTH..............................................................................................................25 4.2.1 Child Growth Monitoring.............................................................................................25 4.2.2 Immunization Coverage..............................................................................................25 4.2.3 NEONATAL MORTALITY...............................................................................................26 4.2.4 Diarrhoeal diseases.....................................................................................................26 4.2.5 Respiratory tract infections.........................................................................................27 4.3 ADOLESCENTS.............................................................................................................27 4.3.1 Deliveries for under 18 years......................................................................................27 4.4 Reproductive health.....................................................................................................28 4.4.1 Family Planning............................................................................................................28 4.5 Cervical cancer screening............................................................................................29 4.6 Preventing Communicable and non-communicable diseases................................30 Communicable Diseases........................................................................................................30 4.6.1 Human Immunodeficiency Virus (HIV).......................................................................30 4.6.2 PRE- ART........................................................................................................................32 4.6.3 VOLUNTARY MALE CIRCUMCISION .........................................................................32 4.6.4 Antiretroviral Therapy (ART)........................................................................................32 4.6.5 Tuberculosis (TB) ..........................................................................................................36 4.6.6 Malaria...........................................................................................................................40 CHAPTER 5: Regional Achievements and Best Practices..........................................................41 5.1 Data...............................................................................................................................42 5.2 Supervision..................................................................................................................42 5.3 Training/Capacity Building..........................................................................................42 5.4 Community Mobilization.............................................................................................42 5.5 Advocacy.......................................................................................................................42 CHAPTER 6: Conclusions & Recommendations........................................................................43 6.1 Conclusions...................................................................................................................44 6.2 Recommendations......................................................................................................44 References:...................................................................................................................................43 LIST OF ACRONYMS ANC Ante-natal care ART Antiretroviral Therapy CTX Cotrimoxazole CPT Cotrimaxazole Preventive Therapy CW Child welfare DBS Dry Blood Spot DNA Deoxyribonucleic Acid FP Family Planning H1N1 Hemmagglutinin 1 Neuraminidase 2 HCW Healthcare workers HIV Human Immune Virus HTC HIV Testing and counselling HMIS Health Management Information System IHM Institute for Health Measurement IPT Isoniazid Preventive Therapy M&E Monitoring & Evaluation M2M Mothers to Mothers MICS Multiple Indicator Cluster Survey MOH Ministry of health NHSSP National Health Sector Strategic Plan OPD Out Patient Department PMTCT Prevention of Mother to child Transmission PNC Post Natal Care RDQA Routine data Quality assessment ReHSAR Regional Health Semi-annual Review RHMT Regional Health Management Team SAM Service Availability Mapping SID Strategic Information Department SNAP Swaziland National AIDS Program STI Sexually Transmitted Infections TB Tuberculosis WHO World Health Organization URC University Research Co.,LLC ACKNOWLEDGEMENT The Lubombo Annual report has been made possible through the tireless hard work of the Health workers in the region. Without their commitment to service delivery, this report would not be possible. The team would also like to thank